5
Participants
Start Date
October 24, 2017
Primary Completion Date
October 22, 2018
Study Completion Date
October 22, 2018
OBV/PTV/r and DSV
OBV/PTV/r (12.5 mg/ 75 mg/ 50 mg) in combination with DSV (250 mg): Two tablets of OBV/PTV/r in the morning and one tablet of DSV in the morning and one tablet of DSV in the evening orally with a meal without regard to fat or calorie content.
Placebo to match OBV/PTV/r and DSV
Placebo to match OBV/PTV/r and DSV
Hannover Medical School, Hanover
Collaborators (1)
AbbVie
INDUSTRY
Hannover Medical School
OTHER